ATE176470T1 - Xanthinderivate - Google Patents

Xanthinderivate

Info

Publication number
ATE176470T1
ATE176470T1 AT91917824T AT91917824T ATE176470T1 AT E176470 T1 ATE176470 T1 AT E176470T1 AT 91917824 T AT91917824 T AT 91917824T AT 91917824 T AT91917824 T AT 91917824T AT E176470 T1 ATE176470 T1 AT E176470T1
Authority
AT
Austria
Prior art keywords
represents hydrogen
different
same
xanthine derivatives
formula
Prior art date
Application number
AT91917824T
Other languages
English (en)
Inventor
Fumio Suzuki
Junichi Shimada
Akio Ishii
Hiromi Nonaka
Nobuo Kosaka
Shunji Hita Ichikawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE176470T1 publication Critical patent/ATE176470T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Led Devices (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT91917824T 1990-10-18 1991-10-17 Xanthinderivate ATE176470T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28017190 1990-10-18

Publications (1)

Publication Number Publication Date
ATE176470T1 true ATE176470T1 (de) 1999-02-15

Family

ID=17621294

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917824T ATE176470T1 (de) 1990-10-18 1991-10-17 Xanthinderivate

Country Status (6)

Country Link
EP (1) EP0559893B1 (de)
AT (1) ATE176470T1 (de)
CA (1) CA2094270C (de)
DE (1) DE69130869T2 (de)
ES (1) ES2130138T3 (de)
WO (1) WO1992006976A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2093403C (en) * 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤
TW252044B (de) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
CA2112031A1 (en) * 1992-12-24 1994-06-25 Fumio Suzuki Xanthine derivatives
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
ATE218139T1 (de) * 1994-02-23 2002-06-15 Kyowa Hakko Kogyo Kk Xanthin-derivate
DE69834500T2 (de) 1997-09-05 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. Xanthinderivative zur behandlung von hirnischämie
CA2315736A1 (en) * 1998-01-05 1999-07-15 Eisai Co., Ltd. Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus
ATE319452T1 (de) * 1999-10-29 2006-03-15 Kyowa Hakko Kogyo Kk Arzneimittel gegen essstörungen
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
BR0306919A (pt) 2002-01-28 2004-11-09 Kyowa Hakko Kogyo Kk Métodos para reduzir ou suprimir a efetividade adversa da terapia de l-dopa e/ou do agonista da dopamina, e para tratamento moderado de l-dopa, composição para tratamento moderado de l-dopa, método para tratar doença de parkinson e/ou complicações motoras de l-dopa, composição para o tratamento da doença de parkinson, e, métodos para prolongar o tratamento eficaz da doença de parkinson, e para tratar os distúrbios de movimento
WO2005000313A1 (ja) * 2003-06-27 2005-01-06 Kyowa Hakko Kogyo Co., Ltd. 抗てんかん剤
EP1709967A4 (de) 2004-01-28 2010-09-15 Kyowa Hakko Kirin Co Ltd Mittel zur behandlung von migräne
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
US7776868B2 (en) * 2006-12-01 2010-08-17 Gilead Palo Alto, Inc. Substituted bicyclic and tricyclic thieno[2,3-d]pyrimidines as A2A adenosine receptor antagonists
MX2009006346A (es) * 2006-12-22 2010-03-03 Sanol Arznei Schwarz Gmbh Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos.
RU2477726C1 (ru) * 2011-10-18 2013-03-20 Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак") Замещенные феноксиуксусные кислоты, их эфиры и амиды, включающие 2,6-диоксо-2,3,6,7-тетрагидро-1н-пурин-8-иловый фрагмент, - антагонисты аденозинового a2a рецептора и их применение
CN110981876B (zh) * 2018-12-21 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423805B1 (de) * 1989-10-20 2000-08-23 Kyowa Hakko Kogyo Kabushiki Kaisha Kondensierte Purinderivate

Also Published As

Publication number Publication date
CA2094270C (en) 1997-01-21
CA2094270A1 (en) 1992-04-19
DE69130869T2 (de) 1999-06-10
EP0559893A4 (en) 1994-07-06
EP0559893A1 (de) 1993-09-15
WO1992006976A1 (en) 1992-04-30
DE69130869D1 (en) 1999-03-18
EP0559893B1 (de) 1999-02-03
ES2130138T3 (es) 1999-07-01

Similar Documents

Publication Publication Date Title
ATE176470T1 (de) Xanthinderivate
DK0784974T3 (da) Fremstilling af xanthinderivater i fast dispersion
ATE243697T1 (de) Substitutierte heterozyclische derivate als crf antagonisten
FI914163L (fi) Heterocykliska derivat.
DE69839735D1 (de) Pyrimidin-5-carboxamid-derivate
ATE105285T1 (de) Salicylaldehyd- und salicylsaeurederivate sowie deren schwefelanaloge, verfahren zu ihrer herstellung und ihre verwendung als herbizide und bioregulatoren.
ATE229012T1 (de) Neue taxanderivate
HUT47789A (en) Compositions containing n-/dihalogeno-acetyl/-oxazolidine derivatives as antidotum substituted with heterocyclic group at the 5-position
FI910503A7 (fi) Nya heterocykliska derivat.
DE69027235D1 (de) Xanthinderivate
EP0358190A3 (de) Polysiloxane mit sterisch gehinderten Gruppen
FI915825L (fi) Heterocykliska foereningar.
DE69813605D1 (de) Benzofuranderivate
FI930429A0 (fi) Nya 1,4-dihyropyridinderivat
DE69731556D1 (de) Fettemulsion, die ein xanthinderivat enthält
TR27090A (tr) Tetrahidropirimidin türevleri.
FI914910L (fi) Heterocykliska foereningar.
IT8719814A0 (it) Composti triazinici derivati dalla 2,2,6,6-tetrametilpiperidina.
EP0884318A4 (de) Kondensierte purinderivate
FI910748A7 (fi) Heterocykliska foereningar.
DE3264253D1 (de) Pyridine derivatives as histamine h2 antagonists
WO1997020814A1 (en) Propenone derivatives
EP0579836A4 (de)
FI913893L (fi) Tricykliska heterocykliska derivat.
DE69121413D1 (de) Pyridyl-pyrimidinderivate als fungizide verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties